Just reported
From Definitive Healthcare's results release of November 5, 2026; its quarterly report has since been filed.
Actual
$54.7M
-9.0% y/y
-1.0% q/q
Guided
$55M
midpoint
Actual
-$0.04
Guided
—
No guide given
Actual
-$5M
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes Definitive Healthcare is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Built from Definitive Healthcare Corp.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
DH · Nasdaq · Healthcare · Health Information Services
$1.24-3.1%Nov 12 close
Figures through September 30, 2026, from the 10-Q filed November 5, 2026
Company outlook: revenue of about $55M for Fiscal Q3 2026 — down 8.4% on a year earlier ($60M)
Grade F
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 18 quarters of Definitive Healthcare Corp.’s grade history. The other 16 go back to August 2022.